US President-elect Donald Trump has picked a leading Covid lockdown sceptic Jay Bhattacharya to be the next director of a key US public health agency.

Trump said he had selected the Stanford University-trained physician and economist to lead the National Institutes of Health (NIH), the world’s biggest government-funded biomedical research entity.

Bhattacharya became the face during the pandemic of a fiercely disputed open letter – known as the Great Barrington Declaration – that opposed widespread lockdowns.

Tuesday’s nomination rounds out Trump’s top public health team. He has already unveiled all 15 posts for his cabinet as he prepares to take office on 20 January.

Earlier this month Trump announced he wanted former rival Robert Kennedy Jr to run the US health department. Kennedy’s vaccine scepticism has alarmed the medical community, though his calls for stricter regulation of food ingredients have won praise.

In a statement Trump said Bhattacharya would work with Kennedy to “restore the NIH to a Gold Standard of Medical Research as they examine the underlying causes of, and solutions to, America’s biggest Health challenges, including our Crisis of Chronic Illness and Disease”.

On Tuesday the president-elect also nominated Jim O’Neill – a former federal health official and close ally of conservative donor Peter Thiel – as deputy secretary of the health department.

But it is Bhattacharya who’s more widely known after he challenged the public health establishment’s response to the Covid outbreak four years ago.

In October 2020, Bhattacharya co-authored an open letter known as the Great Barrington Declaration, calling for an alternative to lockdowns, recommending that the focus should instead be on protecting vulnerable groups such as elderly people.

He remains a vocal critic of how Anthony Fauci – a former director of the US National Institute of Allergy and Infectious Diseases, a division of NIH – handled the pandemic.

Then-NIH director Francis Collins said at the time the Great Barrington Declaration, which came before Covid vaccines were available, was dangerous, dismissing the authors as “fringe experts”.

Bhattacharya is not the only Trump nominee to have criticised the response of US public health agencies to the pandemic.

Trump has also picked Marty Makary, a Johns Hopkins surgeon who opposed the Covid-19 vaccine mandate, to run the Food and Drug Administration (FDA).

Dave Weldon, a physician and former Republican congressman who has also cast doubt on vaccine safety, was picked to run the Centers for Disease Control and Prevention (CDC).

Kennedy and O’Neill’s department of health would oversee all the agencies run by Makary, Weldon and Bhattacharya, but they all need to be confirmed by the Senate.

Last week Trump also nominated TV personality Dr Mehmet Oz to be the Centers for Medicare and Medicaid Services administrator.

While Trump’s picks for US public health agencies have broadly been welcomed by his allies, not all of them have won a positive reception from conservatives.

He has also nominated Dr Janette Nesheiwat, a Fox News medical contributor, to become the next surgeon general.

Her previous comments opposing abortion restrictions and in support of masking schoolchildren during the pandemic have upset some Trump supporters.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is frozen water?

Explore More

Prostate cancer symptoms and treatment: What to check for

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific antigen (PSA) blood test and a scan, as well as a

Cognitive behavioral therapy program aids insomnia in breast cancer survivors

An in-home, voice-activated cognitive behavioral therapy (CBT) program improves insomnia symptoms among breast cancer survivors, according to a study published online Sept. 24 in JAMA Network Open. Claire M. Starling,

Origami paper sensors could help early detection of infectious diseases in new simple, low-cost test

Researchers at Cranfield University have developed an innovative new method for identifying biomarkers in wastewater using origami-paper sensors, enabling the tracking of infectious diseases using the camera in a mobile